XNAS: TCRX
Tscan Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid ...
Read More
1.00
-0.11
(-9.91%)
840.9K
XNAS Volume
XNAS 15 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Tscan Therapeutics Inc is on 20 May 2026 for the purpose of TScan Therapeutics Inc Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Tscan Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..